EuroQol responsive in breast cancer patients

Author：

ISSN： 1173-5503

Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.349, 2002-01, pp. : 11-11

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Validation and Comparison of EuroQol and Short Form 6D in Chronic Prostatitis Patients

By Zhao Fei-li Yue Ming Yang Hua Wang Tian Wu Jiu-hong Li Shu-Chuen

Value in Health, Vol. 13, Iss. 5, 2010-08 ,pp. : 649-656

Blackwell Publishing

Access to resources Recommend Favorite

Improved QOL with capecitabine in breast cancer

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 508, 2006-01 ,pp. : 9-9

Adis International

Access to resources Recommend Favorite

Breast cancer QOL news from ASCO

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 479, 2005-01 ,pp. : 12-12

Adis International

Access to resources Recommend Favorite

Adjuvant chemotherapy harms QOL in breast cancer

Inpharma, Vol. 1, Iss. 1417, 2003-01 ,pp. : 7-7

Adis International

Access to resources Recommend Favorite

Switch to anastrozole benefits QOL in breast cancer

Inpharma, Vol. 1, Iss. 1573, 2007-01 ,pp. : 13-13

Adis International

Access to resources Recommend Favorite